Frankfurt - Delayed Quote EUR
Hansoh Pharmaceutical Group Company Limited (3KY.F)
2.8800
0.0000
(0.00%)
At close: May 23 at 3:29:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
12,260,814
12,260,814
10,103,806
9,382,410
9,935,141
Cost of Revenue
1,105,408
1,105,408
1,030,863
867,010
870,042
Gross Profit
11,155,406
11,155,406
9,072,943
8,515,400
9,065,099
Operating Expense
7,124,290
7,124,290
6,233,622
5,723,917
6,030,200
Operating Income
4,031,116
4,031,116
2,839,321
2,791,483
3,034,899
Net Non Operating Interest Income Expense
988,570
988,570
838,326
250,943
111,275
Pretax Income
5,085,182
5,085,182
3,766,155
2,948,428
3,300,082
Tax Provision
713,357
713,357
488,652
364,681
587,180
Net Income Common Stockholders
4,371,825
4,371,825
3,277,503
2,583,747
2,712,902
Average Dilution Earnings
535
535
-131,759
0
-59,200
Diluted NI Available to Com Stockholders
4,372,360
4,372,360
3,145,744
2,583,747
2,653,702
Basic EPS
0.79
0.74
0.55
0.44
0.46
Diluted EPS
0.76
0.73
0.52
0.44
0.44
Basic Average Shares
5,925,920.5040
5,930,095.6720
5,924,899.0500
5,915,822.1960
5,921,040.1610
Diluted Average Shares
6,021,192.1620
5,949,988.7660
6,019,650.1420
5,929,483.3100
5,997,857.7240
Rent Expense Supplemental
4,507
4,507
5,457
8,651
--
Total Expenses
8,229,698
8,229,698
7,264,485
6,590,927
6,900,242
Net Income from Continuing & Discontinued Operation
4,371,825
4,371,825
3,277,503
2,583,747
2,712,902
Normalized Income
4,335,801.0758
4,335,801.0758
3,158,888.5560
2,523,724.7892
2,734,102.3913
Interest Income
995,259
995,259
905,005
309,085
164,093
Interest Expense
6,689
6,689
66,679
58,142
52,818
Net Interest Income
988,570
988,570
838,326
250,943
111,275
EBIT
5,091,871
5,091,871
3,832,834
3,006,570
3,352,900
EBITDA
5,493,220
5,493,220
4,199,215
3,351,172
3,631,367
Reconciled Cost of Revenue
1,105,408
1,105,408
1,030,863
867,010
870,042
Reconciled Depreciation
401,349
401,349
366,381
344,602
278,467
Net Income from Continuing Operation Net Minority Interest
4,371,825
4,371,825
3,277,503
2,583,747
2,712,902
Total Unusual Items Excluding Goodwill
41,902
41,902
136,299
68,494
-25,789
Total Unusual Items
41,902
41,902
136,299
68,494
-25,789
Normalized EBITDA
5,451,318
5,451,318
4,062,916
3,282,678
3,657,156
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0.0002
Tax Effect of Unusual Items
5,878.0758
5,878.0758
17,684.5560
8,471.7892
-4,588.6087
12/31/2021 - 6/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade